1541-2555

COPD Journal of Chronic Obstructive Pulmonary Disease

Informa UK (Taylor & Francis)

View prefix report (10.3109)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 135 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact135 DOIs
2

Attach ORCID iDs across 134 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact134 DOIs
3

Add license metadata to 132 records

License metadata tells indexers and readers how each article may be reused.

High impact132 DOIs

DOIs for this ISSN

Showing the top 5 of 135 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The Effects of Air Pollution and Temperature on COPD (10.3109/15412555.2015.1089846)
Abstract ORCID License
177.13 229
2 Domiciliary Non-invasive Ventilation in COPD: An Internation… (10.3109/15412555.2015.1108960)
Abstract ORCID License
139.75 72
3 Dietary Patterns and Chronic Obstructive Pulmonary Disease:… (10.3109/15412555.2015.1098606)
Abstract ORCID License
136.96 66
4 Reliability, Agreement and Minimal Detectable Change of the… (10.3109/15412555.2015.1079816)
Abstract ORCID License
133.90 60
5 Impact of Changes in Regular Use of Marijuana and/or Tobacco… (10.3109/15412555.2012.671868)
Abstract ORCID License
133.36 59
6 Differences in Adherence and Non-Adherence Behaviour Pattern… (10.3109/15412555.2015.1118449)
Abstract ORCID License
131.11 55
7 Early Supported Discharge/Hospital At Home For Acute Exacerb… (10.3109/15412555.2015.1067885)
Abstract ORCID License
129.93 53
8 Exercise Ventilatory Inefficiency Adds to Lung Function in P… (10.3109/15412555.2016.1158801)
Abstract ORCID License
129.93 53
9 Antiplatelet Treatment Reduces All-Cause Mortality in COPD P… (10.3109/15412555.2015.1099620)
Abstract ORCID License
129.32 52
10 Efficacy and Safety of Umeclidinium Added to Fluticasone Pro… (10.3109/15412555.2015.1034256)
Abstract ORCID License
125.41 46
11 Predictors of Osteoporosis and Vertebral Fractures in Patien… (10.3109/15412555.2012.667850)
Abstract ORCID License
124.71 45
12 The COPD Assessment Test (CAT): Short- and Medium-term Respo… (10.3109/15412555.2012.671869)
Abstract ORCID License
124.71 45
13 The Prevalence of Alpha-1 Antitrypsin Deficiency Among Patie… (10.3109/15412555.2012.669433)
Abstract ORCID License
122.51 42
14 Epidemiology of Chronic Obstructive Pulmonary Disease (COPD)… (10.3109/15412555.2015.1077506)
Abstract ORCID License
120.96 40
15 Association of Inhaled Corticosteroids with Incident Pneumon… (10.3109/15412555.2015.1081162)
Abstract ORCID License
120.96 40
16 Chronic Airflow Obstruction in a Black African Population: R… (10.3109/15412555.2015.1041102)
Abstract ORCID License
120.15 39
17 Fibrinogen, COPD and Mortality in a Nationally Representativ… (10.3109/15412555.2012.668249)
Abstract ORCID License
118.48 37
18 L-Arginine Pathway in COPD Patients with Acute Exacerbation:… (10.3109/15412555.2015.1045973)
Abstract ORCID License
118.48 37
19 Oscillatory Positive Expiratory Pressure in Chronic Obstruct… (10.3109/15412555.2015.1043523)
Abstract ORCID License
117.62 36
20 End-of-Life Discussion, Patient Understanding and Determinan… (10.3109/15412555.2016.1154034)
Abstract ORCID License
114.86 33
21 Reproducibility and Sensitivity of the 6-Minute Stepper Test… (10.3109/15412555.2014.974733)
Abstract ORCID License
113.89 32
22 Prevalence of Pulmonary Hypertension and its Influence on Su… (10.3109/15412555.2015.1043425)
Abstract ORCID License
113.89 32
23 Results of a Multimodal Program During Hospitalization in Ob… (10.3109/15412555.2015.1043428)
Abstract ORCID License
113.89 32
24 Burden and Unmet Needs of Caregivers of Chronic Obstructive… (10.3109/15412555.2016.1151488)
Abstract ORCID License
113.89 32
25 Cardiac Sympathetic Dominance and Systemic Inflammation in C… (10.3109/15412555.2014.974743)
Abstract ORCID License
111.85 30
26 Patient Anxiety and Depression Moderate the Effects of Incre… (10.3109/15412555.2014.995289)
Abstract ORCID License
110.78 29
27 Relationship between Troponin Elevation, Cardiovascular Hist… (10.3109/15412555.2014.995293)
Abstract ORCID License
110.78 29
28 Association Between Genetic Variations In Surfactant Protein… (10.3109/15412555.2012.676110)
Abstract ORCID License
109.68 28
29 Lung Transplantation in Alpha-1-Antitrypsin Deficiency (10.3109/15412555.2015.1048850)
Abstract ORCID License
109.68 28
30 The Prevalence of Metabolic Syndrome In Chronic Obstructive… (10.3109/15412555.2016.1140732)
Abstract ORCID
108.37 146
31 Lipids of Erythrocyte Membranes of COPD Patients: A Quantita… (10.3109/15412555.2012.668581)
Abstract ORCID License
107.35 26
32 Heart Failure Impairs Muscle Blood Flow and Endurance Exerci… (10.3109/15412555.2015.1117435)
Abstract ORCID License
107.35 26
33 Genetic Variants in <i>IL6R</i> and <i>ADAM19</i> are Associ… (10.3109/15412555.2016.1161017)
Abstract ORCID License
107.35 26
34 Predictors of Mortality in Patients with COPD and Chronic Re… (10.3109/15412555.2015.1067294)
Abstract ORCID License
106.12 25
35 One-Year Safety of Olodaterol Once Daily via Respimat® in Pa… (10.3109/15412555.2014.991864)
Abstract ORCID License
104.85 24
36 Anemia in Chronic Obstructive Pulmonary Disease and the Pote… (10.3109/15412555.2015.1043519)
Abstract ORCID License
104.85 24
37 Predicting In-Hospital Treatment Failure (≤7 days) in Patien… (10.3109/15412555.2015.1057276)
Abstract ORCID License
104.85 24
38 Mucosal-Associated Invariant T Cell Deficiency in Chronic Ob… (10.3109/15412555.2015.1069806)
Abstract ORCID License
104.85 24
39 Sympathetic Activation is Associated with Exercise Limitatio… (10.3109/15412555.2015.1136272)
Abstract ORCID License
104.85 24
40 Elastin Degradation: An Effective Biomarker in COPD (10.3109/15412555.2012.697753)
Abstract ORCID License
103.52 23
41 Spirometric Thresholds for Diagnosing COPD: 0.70 or LLN, Pre… (10.3109/15412555.2012.667851)
Abstract ORCID License
102.13 22
42 Distinct Trajectories of Physical Activity Among Patients wi… (10.3109/15412555.2014.995286)
Abstract ORCID License
102.13 22
43 Comparison of the COPD Assessment Test (CAT) and the Clinica… (10.3109/15412555.2015.1043426)
Abstract ORCID License
102.13 22
44 A Screening Study to Determine the Prevalence of Airway Dise… (10.3109/15412555.2015.1082999)
Abstract ORCID License
100.68 21
45 Health State Utility Value in Chronic Obstructive Pulmonary… (10.3109/15412555.2015.1092953)
Abstract ORCID License
100.68 21
46 Understanding the Association Between Chronic Obstructive Pu… (10.3109/15412555.2015.1132691)
Abstract ORCID License
100.68 21
47 Levels of IL-32 in Serum, Induced Sputum Supernatant, and Br… (10.3109/15412555.2016.1145201)
Abstract ORCID License
100.68 21
48 Maintaining Control of Chronic Obstructive Airway Disease: A… (10.3109/15412555.2015.1045972)
Abstract ORCID License
99.17 20
49 Asthma COPD Overlap Syndrome on CT Densitometry: A Distinct… (10.3109/15412555.2015.1102874)
Abstract ORCID License
99.17 20
50 Is There Any Additional Effect of Tele-Assistance on Long-Te… (10.3109/15412555.2016.1147542)
Abstract ORCID License
99.17 20